UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 346

Sortiert nach

Predicting Bleeding in Cancer-Associated Venous Thromboembolism: Another Milestone Achieved

Thrombosis and haemostasis, 2024-04, Vol.124 (4), p.337

2024

Link zum Volltext

Verfügbarkeit prüfen

Predicting bleeding risk after coronary surgery: Let's focus on modifiable risk factors and simple, practical decision making

Thrombosis and haemostasis, 2017, Vol.117 (4), p.647

2017

Link zum Volltext

Verfügbarkeit prüfen

The importance of excellence in the quality of anticoagulation control whilst taking vitamin K antagonists

Thrombosis and haemostasis, 2015-04, Vol.113 (4), p.671

2015

Link zum Volltext

Verfügbarkeit prüfen

The HAS-BLED Score Has Better Prediction Accuracy for Major Bleeding Than CHADS2 or CHA2DS2-VASc Scores in Anticoagulated Patients With Atrial Fibrillation

Journal of the American College of Cardiology, 2013-12, Vol.62 (23), p.2199-2204

2013

Link zum Volltext

Verfügbarkeit prüfen

Predictive Value of the HAS-BLED and ATRIA Bleeding Scores for the Risk of Serious Bleeding in a “Real-World” Population With Atrial Fibrillation Receiving Anticoagulant Therapy

Chest, 2013, Vol.143 (1), p.179-184

2013

Link zum Volltext

Verfügbarkeit prüfen

Iodine Deficiency in a Study Population of Norwegian Pregnant Women-Results from the Little in Norway Study (LiN)

Nutrients, 2018-04, Vol.10 (4), p.513

2018

Link zum Volltext

Verfügbarkeit prüfen

SAMe-TT2R2 Score, Time in Therapeutic Range, and Outcomes in Anticoagulated Patients with Atrial Fibrillation

The American journal of medicine, 2014-11, Vol.127 (11), p.1083-1088

2014

Link zum Volltext

Verfügbarkeit prüfen

Is the ORBIT Bleeding Risk Score Superior to the HAS-BLED Score in Anticoagulated Atrial Fibrillation Patients?

Circulation Journal, 2016/09/23, Vol.80(10), pp.2102-2108

2016

Link zum Volltext

Verfügbarkeit prüfen

Oral anticoagulation and comorbidities; too many details for clinical practice?

International journal of cardiology, 2018-08, Vol.264, p.93-94

2018

Link zum Volltext

Verfügbarkeit prüfen

Comparison of the 2MACE and TIMI-AF Scores for Composite Clinical Outcomes in Anticoagulated Atrial Fibrillation Patients

Circulation Journal, 2018/04/25, Vol.82(5), pp.1286-1292

2018

Link zum Volltext

Verfügbarkeit prüfen

Renal Impairment in a “Real-Life” Cohort of Anticoagulated Patients With Atrial Fibrillation (Implications for Thromboembolism and Bleeding)

The American journal of cardiology, 2013-04, Vol.111 (8), p.1159-1164

2013

Link zum Volltext

Verfügbarkeit prüfen

Relationship between multimorbidity and outcomes in atrial fibrillation

Experimental gerontology, 2021-10, Vol.153, p.111482, Article 111482

2021

Link zum Volltext

Verfügbarkeit prüfen

Refining Stroke and Bleeding Prediction in Atrial Fibrillation by Adding Consecutive Biomarkers to Clinical Risk Scores

Stroke (1970), 2019-06, Vol.50 (6), p.1372-1379

2019

Link zum Volltext

Verfügbarkeit prüfen

Factor XI, much more than an innocent observer

Journal of thrombosis and haemostasis, 2020-12, Vol.18 (12), p.3172-3173

2020

Link zum Volltext

Verfügbarkeit prüfen

The Atrial Fibrillation Better Care (ABC) Pathway and Clinical Outcomes in Patients with Atrial Fibrillation: the Prospective Murcia AF Project Phase II Cohort

Journal of general internal medicine : JGIM, 2023-02, Vol.38 (2), p.315-323

2023

Link zum Volltext

Verfügbarkeit prüfen

MiR-146a Regulates Neutrophil Extracellular Trap Formation That Predicts Adverse Cardiovascular Events in Patients With Atrial Fibrillation

Arteriosclerosis, thrombosis, and vascular biology, 2018-04, Vol.38 (4), p.892

2018

Link zum Volltext

Verfügbarkeit prüfen

Long-term bleeding risk prediction in 'real world' patients with atrial fibrillation: Comparison of the HAS-BLED and ABC-Bleeding risk scores. The Murcia Atrial Fibrillation Project

Thrombosis and haemostasis, 2017-10, Vol.117 (10), p.1848

2017

Link zum Volltext

Verfügbarkeit prüfen

Impact of particulate matter on the incidence of atrial fibrillation and the risk of adverse clinical outcomes: A review

The Science of the total environment, 2023-07, Vol.880, p.163352-163352, Article 163352

2023

Link zum Volltext

Verfügbarkeit prüfen

Number needed to treat for net effect of anticoagulation in atrial fibrillation: Real‐world vs. clinical‐trial evidence

British journal of clinical pharmacology, 2022-01, Vol.88 (1), p.282-289

2022

Link zum Volltext

Verfügbarkeit prüfen

Assessing Bleeding Risk in Atrial Fibrillation Patients: Comparing a Bleeding Risk Score Based Only on Modifiable Bleeding Risk Factors against the HAS-BLED Score. The AMADEUS Trial

Thrombosis and haemostasis, 2017-12, Vol.117 (12), p.2261

2017

Link zum Volltext

Verfügbarkeit prüfen

The SAMe-TT2R2 Score Predicts Poor Anticoagulation Control in AF Patients: A Prospective ‘Real-world’ Inception Cohort Study

The American journal of medicine, 2015-11, Vol.128 (11), p.1237-1243

2015

Link zum Volltext

Verfügbarkeit prüfen

Characteristics and management of patients with stroke and major hemorrhagic episodes with atrial fibrillation under vitamin K antagonist therapy. EVENTHO study

Medicina clínica, 2022-10, Vol.159 (8), p.366-371

2022

Link zum Volltext

Verfügbarkeit prüfen

Effects of Body Mass Index on the Lipid Profile and Biomarkers of Inflammation and a Fibrinolytic and Prothrombotic State

Journal of Atherosclerosis and Thrombosis, 2015/06/16, Vol.22(6), pp.610-617

2015

Link zum Volltext

Verfügbarkeit prüfen

Quality of oral anticoagulation with vitamin K antagonists in 'real-world' patients with atrial fibrillation: a report from the prospective multicentre FANTASIIA registry

Europace (London, England), 2018-09, Vol.20 (9), p.1435-1441

2018

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 346

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(309)
Mit Volltextzugriff
(292)

Publikationsform

Sprache

5 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(219)
Life Sciences & Biomedicine
(209)
Humans
(198)
Cardiovascular System & Cardiology
(119)
Female
(118)
Male
(116)
Atrial Fibrillation
(94)
Aged
(93)
Risk Factors
(79)
Cardiac & Cardiovascular Systems
(77)
Middle Aged
(70)
Biological And Medical Sciences
(60)
Medical Sciences
(60)
Hematology
(56)
Atrial Fibrillation - Drug Therapy
(52)
Stroke
(49)
Peripheral Vascular Disease
(48)
Aged, 80 And Over
(47)
Anticoagulants - Therapeutic Use
(45)
Atrial Fibrillation - Complications
(44)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Predicting Bleeding in Cancer-Associated Venous Thromboembolism: Another Milestone Achieved

Predicting bleeding risk after coronary surgery: Let's focus on modifiable risk factors and simple, practical decision making

The importance of excellence in the quality of anticoagulation control whilst taking vitamin K antagonists

The HAS-BLED Score Has Better Prediction Accuracy for Major Bleeding Than CHADS2 or CHA2DS2-VASc Scores in Anticoagulated Patients With Atrial Fibrillation

Predictive Value of the HAS-BLED and ATRIA Bleeding Scores for the Risk of Serious Bleeding in a “Real-World” Population With Atrial Fibrillation Receiving Anticoagulant Therapy

Iodine Deficiency in a Study Population of Norwegian Pregnant Women-Results from the Little in Norway Study (LiN)

SAMe-TT2R2 Score, Time in Therapeutic Range, and Outcomes in Anticoagulated Patients with Atrial Fibrillation

Is the ORBIT Bleeding Risk Score Superior to the HAS-BLED Score in Anticoagulated Atrial Fibrillation Patients?

Oral anticoagulation and comorbidities; too many details for clinical practice?

Comparison of the 2MACE and TIMI-AF Scores for Composite Clinical Outcomes in Anticoagulated Atrial Fibrillation Patients

Antithrombotic management in patients undergoing electrophysiological procedures: a European Heart Rhythm Association (EHRA) position document endorsed by the ESC Working Group Thrombosis, Heart Rhythm Society (HRS), and Asia Pacific Heart Rhythm Society (APHRS)

Renal Impairment in a “Real-Life” Cohort of Anticoagulated Patients With Atrial Fibrillation (Implications for Thromboembolism and Bleeding)

Relationship between multimorbidity and outcomes in atrial fibrillation

Refining Stroke and Bleeding Prediction in Atrial Fibrillation by Adding Consecutive Biomarkers to Clinical Risk Scores

Factor XI, much more than an innocent observer

The Atrial Fibrillation Better Care (ABC) Pathway and Clinical Outcomes in Patients with Atrial Fibrillation: the Prospective Murcia AF Project Phase II Cohort

MiR-146a Regulates Neutrophil Extracellular Trap Formation That Predicts Adverse Cardiovascular Events in Patients With Atrial Fibrillation

Long-term bleeding risk prediction in 'real world' patients with atrial fibrillation: Comparison of the HAS-BLED and ABC-Bleeding risk scores. The Murcia Atrial Fibrillation Project

Impact of particulate matter on the incidence of atrial fibrillation and the risk of adverse clinical outcomes: A review

Number needed to treat for net effect of anticoagulation in atrial fibrillation: Real‐world vs. clinical‐trial evidence

Assessing Bleeding Risk in Atrial Fibrillation Patients: Comparing a Bleeding Risk Score Based Only on Modifiable Bleeding Risk Factors against the HAS-BLED Score. The AMADEUS Trial

The SAMe-TT2R2 Score Predicts Poor Anticoagulation Control in AF Patients: A Prospective ‘Real-world’ Inception Cohort Study

Characteristics and management of patients with stroke and major hemorrhagic episodes with atrial fibrillation under vitamin K antagonist therapy. EVENTHO study

Effects of Body Mass Index on the Lipid Profile and Biomarkers of Inflammation and a Fibrinolytic and Prothrombotic State

Quality of oral anticoagulation with vitamin K antagonists in 'real-world' patients with atrial fibrillation: a report from the prospective multicentre FANTASIIA registry

Suchergebnisse filtern